-
公开(公告)号:US10214477B2
公开(公告)日:2019-02-26
申请号:US15497556
申请日:2017-04-26
Applicant: Oryzon Genomics S.A.
Inventor: Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Àngeles Estiarte Martinez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria
IPC: C07C211/36 , C07D213/74 , C07C271/24 , C07C275/26 , C07D231/12 , C07D207/14 , C07D277/28 , C07D295/096 , C07D295/135 , C07D295/26 , C07D213/30 , C07D213/38 , C07D307/52 , C07C311/08 , C07C311/21 , C07C215/46 , C07C217/54 , C07C209/28 , C07C211/38 , C07C269/00 , C07C273/18 , C07C211/40 , C07C213/00 , C07C215/64 , C07C217/74 , C07C273/00 , C07D213/57 , C07D213/73 , C07D231/56 , C07D333/20
Abstract: The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
-
12.(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS 有权
Title translation: (HETERO)ARYL CYPOPRAMLAMINE COMPOUNDS AS LSD1 INHIBITORS公开(公告)号:US20150119396A9
公开(公告)日:2015-04-30
申请号:US14352719
申请日:2012-10-22
Applicant: ORYZON GENOMICS, S.A.
Inventor: Alberto Ortega Muñoz , Matthew Colin Thor Fyfe , Marc Martinell Pedemonte , Maria de los Angeles Estiarte Martínez , Nuria Valls Vidal , Guido Kurz , Julio Cesar Castro Palomino Laria
IPC: C07C211/36 , C07C209/28 , C07D295/135 , C07D213/38 , C07C275/26 , C07D207/14 , C07C271/24 , C07C273/18 , C07C211/38 , C07C269/00 , C07D277/28
CPC classification number: C07C211/36 , C07B2200/07 , C07C209/28 , C07C211/37 , C07C211/38 , C07C211/40 , C07C213/00 , C07C215/46 , C07C215/64 , C07C217/54 , C07C217/74 , C07C269/00 , C07C271/24 , C07C273/00 , C07C273/18 , C07C275/26 , C07C311/08 , C07C311/21 , C07C2601/02 , C07C2601/04 , C07C2601/14 , C07C2602/08 , C07D207/14 , C07D213/30 , C07D213/38 , C07D213/57 , C07D213/73 , C07D213/74 , C07D231/12 , C07D231/56 , C07D277/28 , C07D295/096 , C07D295/135 , C07D295/26 , C07D307/52 , C07D333/20
Abstract: The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and theft use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
Abstract translation: 本发明涉及(异)芳基环丙胺化合物,特别包括本文所述和定义的式(I)化合物和治疗中的盗窃用途,包括例如治疗或预防癌症,神经疾病或病症, 或病毒感染。
-